BG103937A - 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapy - Google Patents
5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapyInfo
- Publication number
- BG103937A BG103937A BG103937A BG10393799A BG103937A BG 103937 A BG103937 A BG 103937A BG 103937 A BG103937 A BG 103937A BG 10393799 A BG10393799 A BG 10393799A BG 103937 A BG103937 A BG 103937A
- Authority
- BG
- Bulgaria
- Prior art keywords
- group
- optionally substituted
- therapy
- nitrogen
- naphthalen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9706944A FR2764287B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
| FR9706947A FR2764291B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
| FR9706945A FR2764288B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
| FR9706946A FR2764289B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
| PCT/FR1998/001113 WO1998055474A1 (fr) | 1997-06-05 | 1998-06-03 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103937A true BG103937A (en) | 2000-07-31 |
Family
ID=27447000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103937A BG103937A (en) | 1997-06-05 | 1999-11-30 | 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapy |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0986552A1 (es) |
| JP (1) | JP2002502412A (es) |
| KR (1) | KR20010013435A (es) |
| CN (1) | CN1265658A (es) |
| AR (1) | AR012908A1 (es) |
| AU (1) | AU8025198A (es) |
| BG (1) | BG103937A (es) |
| BR (1) | BR9810742A (es) |
| CA (1) | CA2290695A1 (es) |
| CO (1) | CO4940480A1 (es) |
| EE (1) | EE9900560A (es) |
| HU (1) | HUP0002166A3 (es) |
| IL (1) | IL133242A0 (es) |
| NO (1) | NO995966L (es) |
| PL (1) | PL337234A1 (es) |
| SK (1) | SK166199A3 (es) |
| TR (1) | TR199903022T2 (es) |
| WO (1) | WO1998055474A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100792814B1 (ko) * | 2000-07-21 | 2008-01-14 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 신경병증 통증 및 군발성 및 편두통성 두통-관련 통증의예방 또는 치료를 위해 사용하기 위한 카바메이트 화합물 |
| FR2843964B1 (fr) | 2002-08-29 | 2004-10-01 | Sanofi Synthelabo | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0461958T3 (da) * | 1990-06-15 | 1995-02-20 | Synthelabo | 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien |
| FR2714055B1 (fr) * | 1993-12-22 | 1996-01-19 | Synthelabo | Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique. |
| FR2742152B1 (fr) * | 1995-12-06 | 1998-01-16 | Synthelabo | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
-
1998
- 1998-06-03 CN CN98807817A patent/CN1265658A/zh active Pending
- 1998-06-03 AR ARP980102585A patent/AR012908A1/es unknown
- 1998-06-03 BR BR9810742-9A patent/BR9810742A/pt not_active IP Right Cessation
- 1998-06-03 EP EP98928419A patent/EP0986552A1/fr not_active Withdrawn
- 1998-06-03 HU HU0002166A patent/HUP0002166A3/hu unknown
- 1998-06-03 KR KR1019997011436A patent/KR20010013435A/ko not_active Application Discontinuation
- 1998-06-03 EE EEP199900560A patent/EE9900560A/xx unknown
- 1998-06-03 IL IL13324298A patent/IL133242A0/xx unknown
- 1998-06-03 AU AU80251/98A patent/AU8025198A/en not_active Abandoned
- 1998-06-03 TR TR1999/03022T patent/TR199903022T2/xx unknown
- 1998-06-03 SK SK1661-99A patent/SK166199A3/sk unknown
- 1998-06-03 PL PL98337234A patent/PL337234A1/xx unknown
- 1998-06-03 JP JP50172399A patent/JP2002502412A/ja active Pending
- 1998-06-03 WO PCT/FR1998/001113 patent/WO1998055474A1/fr not_active Application Discontinuation
- 1998-06-03 CA CA002290695A patent/CA2290695A1/en not_active Abandoned
- 1998-06-04 CO CO98031750A patent/CO4940480A1/es unknown
-
1999
- 1999-11-30 BG BG103937A patent/BG103937A/xx unknown
- 1999-12-03 NO NO995966A patent/NO995966L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO995966D0 (no) | 1999-12-03 |
| HUP0002166A2 (hu) | 2001-06-28 |
| BR9810742A (pt) | 2000-09-12 |
| SK166199A3 (en) | 2000-06-12 |
| CO4940480A1 (es) | 2000-07-24 |
| IL133242A0 (en) | 2001-03-19 |
| AR012908A1 (es) | 2000-11-22 |
| EE9900560A (et) | 2000-06-15 |
| CA2290695A1 (en) | 1998-12-10 |
| NO995966L (no) | 2000-02-04 |
| PL337234A1 (en) | 2000-08-14 |
| HUP0002166A3 (en) | 2002-12-28 |
| EP0986552A1 (fr) | 2000-03-22 |
| WO1998055474A1 (fr) | 1998-12-10 |
| JP2002502412A (ja) | 2002-01-22 |
| CN1265658A (zh) | 2000-09-06 |
| AU8025198A (en) | 1998-12-21 |
| TR199903022T2 (xx) | 2000-04-21 |
| KR20010013435A (ko) | 2001-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG108091A (en) | Quinazolines and mmp-13 inhibitors | |
| IL150650A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| NZ502181A (en) | Triazole compounds and the use thereof as dopamine-D 3-ligands | |
| MY125749A (en) | Aralkyl and aralkylidene heterocyclic lactams and imides | |
| PT1204643E (pt) | Amidas aromáticas heterocíclicas fungicidas e suas composições, métodos de utilização e preparação | |
| BG106013A (en) | New compounds and compositions as protease inhibitors | |
| MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
| AP9801169A0 (en) | N-hydroxy-B-sulfonyl propionamide derivatives. | |
| GB9914486D0 (en) | Medicaments | |
| MXPA02012034A (es) | Derivados de tiofeno utiles como agentes anticancerosos. | |
| IL148014A0 (en) | Cell adhesion inhibitors | |
| BG106343A (en) | Carboxylic acid amides, medicaments containing these compounds and the use and production thereof | |
| BG105028A (en) | Bridged indenopyrrolocarbazoles | |
| TW342385B (en) | Bicyclic benzazepin, the process for their preparation and the pharmaceutical composition containing them | |
| MX9806171A (es) | Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa. | |
| MY100115A (en) | Nitrogen containing heterocyclic compounds, and their production and use. | |
| BG102015A (en) | Azacycloalkane derivatives, their preparation and application in therapy | |
| IL133279A0 (en) | Carboxamides useful as 5-ht1f agonists | |
| DK0648760T3 (da) | Triazinderivat og dets fremstilling og anvendelse | |
| BG105710A (en) | 5ht1 antagonists for antidepressant therapy | |
| MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
| DE60015146D1 (en) | Serotonerge benzothiophene | |
| TW351718B (en) | Acylated aminoalkanimidazoles and -triazoles | |
| AP2000002008A0 (en) | Tetrahydroquinoline derivatives as glycine antagonists. | |
| BG103937A (en) | 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapy |